Avacta Group (AVCT)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

49.83p
   
  • Change Today:
      0.83p
  • 52 Week High: 159.60
  • 52 Week Low: 47.33
  • Currency: UK Pounds
  • Shares Issued: 350.51m
  • Volume: 3,101,707
  • Market Cap: £174.67m
  • RiskGrade: 461

Avacta antigen lateral flow test shown to detect Omicron

By Michele Maatouk

Date: Wednesday 15 Dec 2021

LONDON (ShareCast) - (Sharecast News) - Aim-listed Avacta said on Wednesday that its AffiDX® antigen lateral flow test has been shown to detect the Omicron variant of the SARS-CoV-2 virus in clinical samples.
The AIM-listed clinical stage biopharmaceutical company said the lateral flow test has been evaluated at the Carlos III Hospital in Madrid using a small number of actual patient samples confirmed to be Omicron variant positive.

The results indicate that it detects the new Omicron variant in addition to all previously identified new variants of concern.

Chief executive Dr Alastair Smith said: "We are delighted to confirm that the AffiDX® SARS-CoV-2 antigen lateral flow test detects the Omicron variant. As this variant is more infectious, it is important that it can be detected in individuals with higher loads using lateral flow tests so that its spread can be slowed down.

"We are progressing with our application to the CTDA in order to put the AffiDx product on the market in the UK, as well as continuing to pursue commercial opportunities in Europe and further afield for the professional-use test. We also continue to work with our partners, Medusa 19 Healthcare, to obtain the CE mark for consumer self-testing for the product which is a critical next step in the commercialisation of the product."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Avacta Group Market Data

Currency UK Pounds
Share Price 49.83p
Change Today 0.83p
% Change 1.70 %
52 Week High 159.60
52 Week Low 47.33
Volume 3,101,707
Shares Issued 350.51m
Market Cap £174.67m
RiskGrade 461

Avacta Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
35.15% below the market average35.15% below the market average35.15% below the market average35.15% below the market average35.15% below the market average
48.15% below the sector average48.15% below the sector average48.15% below the sector average48.15% below the sector average48.15% below the sector average
Price Trend
61.94% below the market average61.94% below the market average61.94% below the market average61.94% below the market average61.94% below the market average
29.82% below the sector average29.82% below the sector average29.82% below the sector average29.82% below the sector average29.82% below the sector average
Income Not Available
Growth
58.30% above the market average58.30% above the market average58.30% above the market average58.30% above the market average58.30% above the market average
78.38% above the sector average78.38% above the sector average78.38% above the sector average78.38% above the sector average78.38% above the sector average

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 1
Strong Sell 0
Total 2
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Avacta Group Dividends

No dividends found

Trades for 28-Mar-2024

Time Volume / Share Price
16:21 1,003 @ 49.82p
16:20 250,000 @ 49.50p
16:19 1,994 @ 49.83p
16:19 16,000 @ 49.84p
16:18 16,000 @ 49.63p

Avacta Group Key Personnel

CEO Alastair Smith
CFO Tony Peter Gardiner

Top of Page